RNA-associated Proteinases: Potential Drug Targets (G440400)
RNA-associated Proteinases: Potential Drug Targets
RNA-associated proteinases (RNASes) are a family of enzymes that have been identified as potential drug targets in various diseases. One of the best-known RNASes is RNASEK (RNA-associated proteinase K), which is a highly conserved protein that is involved in the regulation of gene expression. RNASEK plays a crucial role in the regulation of stem cell proliferation and differentiation, and its dysfunction has been implicated in numerous diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
The RNA-associated proteinases (RNASes) are a family of enzymes that have been identified as potential drug targets in various diseases. These enzymes belong to the RNA-protein subfamily and are characterized by their ability to process RNA. RNASes are involved in the regulation of gene expression, DNA replication, and RNA splicing and other biological processes. They are also involved in the regulation of stem cell proliferation and differentiation, and their dysfunction has been implicated in numerous diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
One of the best-known RNASes is RNASEK (RNA-associated proteinase K), which is a highly conserved protein that is involved in the regulation of gene expression. RNASEK is a 21 kDa protein that is expressed in various tissues and cells, including muscle , heart, liver, and brain. It is highly conserved, with a calculated identity of 96.8% among the 30 known mammalian species.
RNASEK is involved in the regulation of gene expression by processing RNA pre-mRNA, post-mRNA, and microRNA (miRNA). It is a key enzyme in the RNA-protein complex, which is responsible for the processing and modification of RNA. The RNA-protein complex is composed of various proteins, including RNA-proteinases, RNA-binding proteins, and non-coding RNAs.
RNASEK is involved in the regulation of stem cell proliferation and differentiation. Stem cells are undifferentiated cells that have the potential to develop into any cell type in the body. They are an attractive drug target due to their ability to self-renew and differentiate into various cell types. RNASEK is involved in the regulation of stem cell proliferation by processing miRNA, which is a small non-coding RNA molecule that plays a role in post-transcriptional gene regulation.
In addition to its role in stem cell biology, RNASEK is also involved in the regulation of gene expression in various other cell types. It is involved in the regulation of gene expression in the liver, where it is involved in the processing of miRNA that regulates the expression of genes involved in metabolism and regeneration. It is also involved in the regulation of gene expression in the muscle, where it is involved in the processing of miRNA that regulates the expression of genes involved in muscle growth and repair.
RNASEK is also involved in the regulation of gene expression in the nervous system. It is involved in the processing of miRNA that regulates the expression of genes involved in neurotransmission and behavior. endoplasmic reticulum, where it is involved in the processing of exported proteins and the regulation of protein levels.
In conclusion, RNASEK is a highly conserved protein that is involved in the regulation of gene expression. Its dysfunction has been implicated in numerous diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Therefore, RNASEK is a promising drug target for the development of new therapies.
Protein Name: Ribonuclease K
Functions: Endoribonuclease which preferentially cleaves ApU and ApG phosphodiester bonds. Hydrolyzes UpU bonds at a lower rate (PubMed:17881363). Regulates the activity of vacuolar (H+)-ATPase (V-ATPase) which is responsible for acidifying and maintaining the pH of intracellular compartments (PubMed:26212330). Required at an early stage of receptor-mediated endocytosis (PubMed:26212330)
The "RNASEK Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNASEK comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
RNASEL | RNASET2 | RND1 | RND2 | RND3 | RNF10 | RNF103 | RNF103-CHMP3 | RNF11 | RNF111 | RNF112 | RNF113A | RNF113B | RNF114 | RNF115 | RNF121 | RNF122 | RNF123 | RNF125 | RNF126 | RNF126P1 | RNF128 | RNF13 | RNF130 | RNF133 | RNF135 | RNF138 | RNF138P1 | RNF139 | RNF139-DT | RNF14 | RNF141 | RNF144A | RNF144B | RNF145 | RNF146 | RNF148 | RNF149 | RNF150 | RNF151 | RNF152 | RNF157 | RNF157-AS1 | RNF165 | RNF166 | RNF167 | RNF168 | RNF169 | RNF17 | RNF170 | RNF175 | RNF180 | RNF181 | RNF182 | RNF183 | RNF185 | RNF186 | RNF187 | RNF19A | RNF19B | RNF2 | RNF20 | RNF207 | RNF208 | RNF212 | RNF212B | RNF213 | RNF213-AS1 | RNF214 | RNF215 | RNF216 | RNF216-IT1 | RNF216P1 | RNF217 | RNF217-AS1 | RNF220 | RNF222 | RNF224 | RNF225 | RNF227 | RNF24 | RNF25 | RNF26 | RNF31 | RNF32 | RNF32-DT | RNF34 | RNF38 | RNF39 | RNF4 | RNF40 | RNF41 | RNF43 | RNF44 | RNF5 | RNF5P1 | RNF6 | RNF7 | RNF7P1 | RNF8
